CapsoVision, Inc. (CV)
$6.78+0.30%Close
BUYRECOVERY · day 33
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $339M
- Beta
- -2.46
- P/E (TTM)
- -10.54
- Short % float
- 53.62%
- Days to cover
- 5.4
- SI change
- +10.8%
- 1W
- +4.31%
- 1M
- +4.15%
- vs SPY 1W
- +4.45%
- vs SPY 1M
- +1.64%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 1
- VALUE
- 0
- GROWTH
- 12
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-106.7%
REV YoY-
ROE-177.8%
EPS YoY-
ROA-160.6%
GROSS51
OP-159
NET-215
[VALUATION]
P/E TTM-10.54
P/E FWD-
SECTOR PE20.48
INDUSTRY PE22.31
P/B25.18
P/FCF-
EV/EBITDA-11.77
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E5.22
ALTMAN Z-
CURR RATIO3.35
ND/EBITDA-
BETA-2.46
Company news
FAQ
- What is LOPJLB’s current signal on CV?
- LOPJLB’s latest quantitative signal on CapsoVision, Inc. (CV) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is CV in?
- CapsoVision, Inc. (CV) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does CapsoVision, Inc. (CV) do?
- CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measuremen…